Name of Company: Corindus Vascular Robotics
CorPath Vascular Robotics System: The Massachussets company has developed the robot to provide a safer, better alternative to the manual angioplasty and percutaneous coronary interventions.
The system comprised a bedside robotic device that is controlled by the surgeon at an interventional cockpit. The cockpit also houses screens through which surgeons can get real time images of the anatomy being treated. The device is cleared by the FDA and has CE Mark.
Source: Corindus Vascular Robotics